Breaking News
November 12, 2018 - Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimer’s Disease (CTAD)
November 12, 2018 - Scientists reveal new cystic fibrosis treatments work best in inflamed airways
November 12, 2018 - Testing coronary calcium levels can better predict patient’s risk for coronary heart disease
November 12, 2018 - FDA conducts mass seizure of food and medical products held under insanitary conditions
November 12, 2018 - FDA Approves Invokana (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
November 12, 2018 - Hormone helps reverse brain damage caused by obesity
November 12, 2018 - Grants aim to provide better cancer clinical trial access for military veterans
November 12, 2018 - Mitochondrial DNA may have strong influence on cellular metabolism and disease susceptibility
November 12, 2018 - High stakes, entrenched interests and the Trump rollback of environmental regs
November 12, 2018 - Stem cells transplanted for treatment of Parkinson’s disease
November 12, 2018 - Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
November 12, 2018 - Protein found in patients with severe asthma can help identify who would benefit from targeted drugs
November 12, 2018 - Experts develop a list of competencies in antimicrobial prescribing and stewardship
November 12, 2018 - Allied BioScience receives approved label from EPA for new bacteriostatic surface coating
November 12, 2018 - FDA announces emergency use authorization of Ebola fingerstick test with portable reader
November 12, 2018 - Grieving spouses with sleep problems have increased risk of chronic immune activation
November 12, 2018 - Exercise routines affect mental health in Japanese expatriates
November 12, 2018 - Fish oil and vitamin D pills no guard against cancer or serious heart trouble
November 12, 2018 - Excess Gestational Weight Gain Not Better for Child Bone Health
November 12, 2018 - Immune receptor provides protective immunity against Group A Streptococcus
November 12, 2018 - Scientists develop new method to produce irradiated nanomaterials for medical applications
November 12, 2018 - Blue light exposure decreases blood pressure
November 12, 2018 - Researchers discover two proteins essential for development of skeletal muscle
November 12, 2018 - Yelp reviews help understand strengths, weaknesses of emergency departments and urgent care centers
November 12, 2018 - Adolescent obesity linked with increased risk of pancreatic cancer later in life
November 12, 2018 - AHA: Poor Teeth-Brushing Habits Tied to Higher Heart Risk
November 12, 2018 - Researchers find how natural killer cells regulate protective HIV antibodies
November 12, 2018 - Rutgers receives $4.2 million federal grant to improve mental health services
November 12, 2018 - Sussex scientists develop a piece of hardware to show how brains function
November 12, 2018 - Study shows pivotal role of parents in efforts to change sexual orientation of LGBT teens
November 12, 2018 - Neck scan detects dementia way before symptoms appear
November 12, 2018 - Risk-profiling can benefit HIV prevention
November 12, 2018 - New thrombolytic based on magnetite nanoparticles successfully tested on animals
November 12, 2018 - Smoking rates go down in the US, lowest since 1965
November 12, 2018 - Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint
November 12, 2018 - Moderate exercise before conception resulted in lower body weight, increased insulin sensitivity of offspring
November 11, 2018 - Community choirs for older adults reduce loneliness and increase interest in life
November 11, 2018 - Trevena Receives Complete Response Letter for Oliceridine from FDA
November 11, 2018 - More adults and children are using yoga and meditation
November 11, 2018 - Female smokers at greater risk of heart attacks, finds study
November 11, 2018 - Happy Childhood Memories Associated With Better Health
November 11, 2018 - X-linked infantile spinal muscular atrophy – Genetics Home Reference
November 11, 2018 - RNA thought to spread cancer shows ability to suppress breast cancer metastasis
November 11, 2018 - Study finds that thymus plays key role during normal pregnancy
November 11, 2018 - Exploring why some athletes ice their muscles after exercise
November 11, 2018 - Female Genital Mutilation Decreasing in African Nations
November 11, 2018 - Are humans immune to the CRISPR-Cas9 gene editing scissors?
November 11, 2018 - Breastmilk and saliva mixtures regulate oral microbiome of newborn babies
November 11, 2018 - Learning familiar faces through social interactions reduces variability in face recognition
November 11, 2018 - New open source decision support tool could help clinicians chose chemotherapy drugs
November 11, 2018 - New weapons drawn in global TB fight
November 11, 2018 - UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
November 11, 2018 - Surgery restores boy’s ability to walk post-acute flaccid myelitis
November 11, 2018 - Comorbidity negatively impacts quality of life in people with dementia
November 11, 2018 - Neuroscientists receive $16.75 million from BRAIN Initiative to decipher the brain’s visual system
November 11, 2018 - Purdue researchers invent new smart drainage device to help glaucoma patients
November 11, 2018 - New initiative may benefit entrepreneurs working to transform patient care
November 11, 2018 - Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of Zulresso (brexanolone) Injection for Treatment of Postpartum Depression
November 11, 2018 - Exercise could delay progression of type 1 diabetes when first diagnosed
November 11, 2018 - Study of gaze fixation in monkeys reveals role of dopamine neurons in response inhibition
November 11, 2018 - Bilingual therapy is vital to improve language disorders in dual-language children, finds study
November 11, 2018 - More Frequent Surveillance No Benefit After NSCLC Resection
November 11, 2018 - Phenylketonuria (PKU) Screening: MedlinePlus Lab Test Information
November 11, 2018 - Researchers discovered a new mechanism of action in a first-line drug for diabetes
November 11, 2018 - Study explains how dermal fibroblasts age
November 11, 2018 - New multi-allergen test works just as well with dried blood
November 11, 2018 - CWRH/UH researcher receives grant to study role of KLF2 factor in vascular-related disorders
November 11, 2018 - New infrared detector may transform smartphones into pocket-sized portable labs
November 11, 2018 - AHA: Young Golfer Returns to Sport He Loves After Stroke
November 11, 2018 - Yuan-Harel-Lupski syndrome – Genetics Home Reference
November 11, 2018 - Effective diagnosis of persistent facial pain will benefit patients and save money
November 11, 2018 - Loyola tests new catheter ablation system that can reach deeper into heart muscle
November 11, 2018 - Pilates exercise program offers many benefits for people with musculoskeletal conditions
November 11, 2018 - Mutant p53 protein ‘tackles’ DNA guardian to drive tumor development
November 11, 2018 - House Dems in new seats of power will steer health policy, attack drug prices
November 11, 2018 - Maximal longevity in species can be better explained by number of neurons in the brain
November 10, 2018 - Research on designing, delivering, physical activity programs for different audiences
November 10, 2018 - Why heart contractions are weaker in those with hypertrophic cardiomyopathy
November 10, 2018 - AbbVie’s Upadacitinib Shows Significant Improvements in Physical Function, Pain and Quality of Life as a Monotherapy in Patients with Rheumatoid Arthritis in Phase 3 Patient-Reported Outcomes Data
November 10, 2018 - Acute Flaccid Myelitis: MedlinePlus
Cell-Free DNA May Help Pinpoint Breast Ca Survival

Cell-Free DNA May Help Pinpoint Breast Ca Survival

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that a high tumor fraction of cell-free DNA is prognostic of worse survival in patients with metastatic triple-negative breast cancer.
  • Be aware that this disease carries a poor prognosis overall, making further risk stratification an important step towards targeting potentially toxic therapies.

The tumor fraction of cell-free DNA (cfDNA) sample can be used to predict survival in patients with metastatic triple-negative breast cancer (TNBC), investigators reported.

This suggests that determining cfDNA tumor fraction via a minimally invasive blood test can provide “important prognostic information beyond standard clinicopathologic factors,” according to Daniel G. Stover, MD, of the Ohio State University Comprehensive Cancer Center in Columbus, and colleagues.

A diagnosis of TNBC means that the breast cancer cells have tested negative for hormone epidermal growth factor receptor 2 (HER-2), and estrogen and progesterone receptors. TNBC accounts for 10% to 15% of breast cancers, yet is responsible for more than one-third of breast cancer deaths, the authors wrote in the Journal of Clinical Oncology.

They also noted that TNBC is characterized by relatively few mutations, but widespread somatic copy number alterations (SCNAs), suggesting SCNAs play a critical from in the formation of TNBC tumors. Stover’s group evaluated SCNAs in metastatic TNBC via cfDNA to determine whether cfDNA tumor fraction was associated with overall metastatic TNBC survival.

For this retrospective cohort study, they identified 506 plasma samples from 164 patients with biopsy-proven metastatic TNBC. All patients received chemotherapy before blood collection, with most patients receiving neoadjuvant or adjuvant anthracycline and taxane-based chemotherapy.

The researchers used an algorithm, ichorCNA, to profile SCNAs and quantify tumor fraction (TFx) in cfDNA from low-coverage whole-genome sequencing without prior knowledge of the genomic changes in the patient’s tumor.

Stover’s group was able to determine tumor fraction of cfDNA for 158 patients (96.3%). Also, 101 of those 158 patients (63.9%) had at least one sample with TFx equal to or greater than the prespecified cfDNA tumor fraction threshold of 10%.

Crucially, they found that patients with the higher tumor fraction of ≥10% was associated with a “significantly shorter survival” — median 6.4 months versus 15.9 months — and that this association remained significant independent of clinicopathologic factors (hazard ratio 2.14, 95% CI 1.4-3.8).

The analysis also identified several genes — NOTCH2, AKT2, and AKT3 — that had copy number gains enriched in metastatic TNBCs relative to primary TNBCs. In an accompanying commentary, Sarah-Jane Dawson, MD, PhD, of the Peter MacCallum Cancer Center in Melbourne, Australia, and colleague observed that this “sheds light on important genes and signaling pathways that may be perturbed in metastatic disease.”

Stover’s group also found that more than half of metastatic TNBCs harbored gains or amplification of 18q11, 19p13, or both, which was significantly more frequent than in primary TNBCs. “Gain or amplification of both regions identifies a subset of TNBC rapid progressors with remarkably poor survival in the metastatic, and also the primary setting,” they wrote.

The study illustrates a “framework for minimally invasive genomic characterization of metastatic cancer and subsequent integration with clinicopathologic data and patient outcomes,” the authors noted. “This approach has the potential to reveal clinically useful biomarkers while identifying unique genomic features of metastatic cancer and may advance our understanding of metastasis, drug resistance, and novel therapeutic targets.”

Dawson’s group wrote that with “the current lack of prognostic markers in metastatic TNBC, a reliable marker that can be obtained using a minimally invasive blood draw could have important implications.”

They also pointed out that it was important to note that the SCNA analysis was only performed on those patients (63.9% of the cohort) whose TFx was ≥10%. “High-confidence copy number calls could not be achieved for samples with a TFx < 10%, " they wrote, adding this would "limit the applicability of this approach in patients with early-stage disease."

But considering the challenges posed by the heterogeneity of TNBC, and the lack of targeted therapeutic options in treating the disease, the “era of comprehensive molecular characterization promises to pave the way forward,” Dawson’s group wrote.

The study was supported by the Gerstner Family Foundation, Susan G. Komen for the Cure, The Pink Agenda, Breast Cancer Research Foundation, the V Foundation for Cancer Research, and Dana-Farber/Harvard Cancer Center National Cancer Institute Specialized Programs of Research Excellence in Breast Cancer.

Stover disclosed no relevant relationships with industry. Co-authors disclosed multiple relevant relationships with industry.

Dawson and co-author disclosed support from Cancer Therapeutics CRC, the National Breast Cancer Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-12-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles